Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 6.11
+0.15 (2.52%)
Jul 3, 2026, 5:29 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 374.84 million as of July 2, 2026. Its market cap has decreased by -1.55% in one year.
Market Cap
374.84M
Enterprise Value
319.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.11
Market Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 374.84M, an increase of 220.14%. That is a compound annual growth rate of 9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 374.84M | 9.31% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 701.77M |
| FluoGuide | 686.67M |
| Oncopeptides AB | 649.85M |
| Cantargia AB | 533.52M |
| Corline Biomedical AB | 482.16M |
| Intervacc AB | 444.42M |
| Sprint Bioscience AB | 436.83M |
| Ascelia Pharma AB | 395.26M |